Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-21

Clinical Trial Update: Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine therapy with paclitaxel and carboplatin in patients undergoing surgery for advanced ovarian cancer, primary peritoneal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • PACLITAXEL (PACLITAXEL)
  • Vaccine therapy

Snippet

Sponsor: Craig L Slingluff, Jr | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-09-21